Using Exhaled Air to Determine Changes in Nutritional Status of Patients on Intravenous Nutrition

This is a prospective, pilot study to determine if there is change in the 12C/13C BDV between days 0-7 in patients who receive parenteral nutrition. Investigators will recruit subjects from inpatient units at the University of Wisconsin Hospital and Clinics whose primary team consult the Nutrition Support Team to institute parenteral nutrition for clinical reasons. Subjects with clinical indications for parenteral nutrition are moderately to severely malnourished due to little to no nutrition by other means (oral nutrition or nutrition per tube) for a period of time (0-10 days based on state of nourishment prior to admission).

Investigators will record baseline nutritional status from the medical record notes (dietitian, Nutrition Support Team, etc.), as well as medication, demographic information and medical history. Investigators will take a baseline exhaled CO2 measurement and then a daily measurement at approximately the same time daily (+/- an hour).

The daily exhaled 12C/13C breath delta value will be matched with the subjects' daily caloric intake from parenteral nutrition (and oral nutrition and nutrition per tube, if applicable). The breath delta value, the caloric intake, plus the subjects' degree of malnourishment will be parameters with which to build further research. Investigators hypothesize that the breath delta value will increase from baseline and then stabilize after the patient reaches goal energy needs as defined by the Nutrition Support Team.

Inclusion criteria

• 18 years of age or older
• Anticipated start of parenteral nutrition
• Expected duration of stay at least 5 days from enrollment
• Subject speaks English
• Subjects with inability to take adequate oral nutrition who are developing or have developed malnutrition who require parenteral nutrition

Exclusion criteria

• Subjects unable to coordinate well enough to give a 1 liter breath sample
• Subjects receiving parenteral nutrition prior to admission
• Subjects who are pregnant
• Subjects who are prisoners
• Subjects who are pharmacologically sedated or with altered consciousness
• Subjects who are mechanically ventilated
• Subjects admitted for bone marrow or stem cell transplants
• Known participation in another interventional research study within 30 days prior to enrollment (note: to be eligible, any interventional treatment must have ended at least 30 days ago)
• Subjects with disease states or clinical conditions that do not make them study candidates, per the primary investigator's discretion